| Also known as |
Clindamycin 2-phosphate |
| Blood pressure |
No significant impact |
| Chemical name |
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-О±-D-galacto-octopyranoside 2-(dihydrogen phosphate) |
| Dosage (medical) |
150-450 mg orally every 6 hours or 600-900 mg IV every 8 hours, depending on the severity of the infection |
| Dosage (sports) |
Not applicable |
| Effects |
Inhibits bacterial protein synthesis, leading to the death of bacteria |
| Formula |
C18H34ClN2O8PS |
| Half-life |
2.4 hours |
| Hepatotoxicity |
Rare, but cases of hepatitis and liver dysfunction have been reported |
| Lab Test |
Monitoring of liver and renal functions may be required |
| Main action |
Antimicrobial |
| Side effects |
Nausea, vomiting, diarrhea, abdominal pain, rash, itching, and potential for pseudomembranous colitis |
| Storage conditions |
Store at 20В° to 25В°C (68В° to 77В°F) |
| Substance class |
Antibiotic |
| Trade name |
Cleocin |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Manufacturer |
Pharmaceutical |
